Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.
For the digital health and pharma suppliers we cover, February was a month of changes, with CEOs coming and going (sometimes dramatically), and several other C-Suite and board shake-ups.
Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.